MA Yaxin1, LI Shuqiong1, LI Yunxiang1, SUN Yonghong2▲

Corresponding author: Sun Yonghong, Sunyonghong7615@126.com

DOI: 10.12201/bmr.202504.00073

•  

  Abstract: Mycoplasma pneumoniae pneumonia (MPP) is one of the leading pathogens of community-acquired pneumonia (CAP) in children, with a significantly increasing incidence in recent years. The proportion of severe MPP cases has also been rising, making it a major focus of clinical research due to its severe condition, rapid progression, treatment challenges, and high risk of complications. Recent studies have demonstrated that serological biomarkers play a crucial role in the early identification and disease assessment of severe MPP, including C-reactive protein (CRP), procalcitonin (PCT), erythrocyte sedimentation rate (ESR), D-dimer (D-D), lactate dehydrogenase (LDH), and tumor necrosis factor-alpha (TNF-α). This review summarizes recent research on the early prediction of severe MPP in children, providing valuable insights for its early diagnosis.

  Key words: Mycoplasma pneumoniae pneumonia; severe mycoplasma pneumoniae pneumonia; early prediction; research progress

  Submit time: 27 April 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• YE Hongzhou, YUAN Chen. Risk factors of severe pneumonia in children with macrolide-resistant Mycoplasma pneumoniae pneumonia and the construction of prediction model. 2024. doi: 10.12201/bmr.202409.00021

  GENG Gang, LI Shaojun. Mycoplasma pneumoniae encephalitis in children: a case report and literature review. 2024. doi: 10.12201/bmr.202408.00042

  Li Feifan, Zhang shuitang. Impact of Mixed Infections and Antibiotic Resistance Genes on Clinical Features in Children with Mycoplasma pneumoniae Pneumonia. 2024. doi: 10.12201/bmr.202412.00025

  Wu Xiayang. Evaluation of the effectiveness and safety of generic and original azithromycin for the treatment of pediatric mycoplasma pneumonia. 2025. doi: 10.12201/bmr.202501.00071

  周妮, GU Qiang. Risk factors and risk prediction for the course of lobar pneumonia in children. 2025. doi: 10.12201/bmr.202504.00059

  Zhang Lina, Zhang qiuyue, Li Zhen, Tian Jia. Changes and Significance of Coagulation Function Indicators in Elderly Patients with Severe Pneumonia. 2024. doi: 10.12201/bmr.202411.00035

  . 2024. doi: 10.12201/bmr.202411.00065

  gaoweiwei, lijialin, liudaijian, wangyulin. Correlational Analysis of Immune-Inflammatory Markers with the Clinical Outcomes of Severe Pneumonia. 2024. doi: 10.12201/bmr.202409.00062

  wang nan, li lingyan, yang yanhui, gao fangfang, yang mei, qi aixia, chen liping. Analysis of Detection and Epidemiological Characteristics of Respiratory Pathogens in Children in Zibo from 2020 to 2022. 2025. doi: 10.12201/bmr.202504.00019

  ZHANG Zhi-feng, BAO Jun, TAO Yue, LI Zhi-yu. Analysis Of Infection Status And Drug Sensitivity Of Mycoplasma And Chlamydia In 2324 Outpatients. 2025. doi: 10.12201/bmr.202504.00025

• ID	Submit time	Number	Download
  1	2025-03-14	bmr.202504.00073V1	Download

• Public  Anonymous  To author only Submit Comments